RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF
Conditions: Hepatitis B; Acute-On-Chronic Liver Failure Interventions: Other: Plasma exchange; Other: RL-1 Novel Human-derived Bio-artificial Liver Treatment Sponsor: Third Affiliated Hospital, Sun Yat-Sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials